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die pasient deur die noodtoestand te loods en horn in groep
ill te plaas.
Groep Ill. Gevalle wat herstel van die eerste blneding,
maar wat sterf by 'n herhaling, gewoonlik gedurende die 2e
week van hul hospitaalverblyf. Hierdie gevalle behoort
angiografies bestudeer te word en crururgies behandel te
word in die stilperiode voor die herhaling van die bloeding,
en bier meen ons dat lumbaalpunksie en 'n studie van die
xantokromie behulpsaam is. Volgens Ballantine en Klein20
is dit ,die toestand van die pasient eerder as 'n spesifieke
wag-periode na die bloeding wat die optimum tyd vir
chirurgiese ingreep behoort te bepaal'. Dit is duidelik uit
Afb. 1 dat as xantokromie begin verminder, dit spoedig
verdwyn (soms binne 48 uur). Ons het gevind dat die kliniese
beeld min of rneer parallel verloop met die graad van xanto-
kromie. Dit wil dus voorkom of die optimale tyd vir angio-
grafiese ondersoek en chirurgie op die tydstip is wanneer
die vog helder word of minstens 'n ligterwordende xanto-
kromie toon. Dit sou dan dui op angiografie teen ongeveer
die 15e dag, maar help by individuele beslissings aangesien
xantokromie in sommige gevalle reeds tussen die 3e en 7e
dag verdwyn het.
Groep IV. Gevalle sonder bewussynsverlies of slegs kort-
stondige bewussynsverlies by die begin met gunstige verdere
verloop. Baie van die reekse wat chirurgiese behandeling
ontvang het, bestaan uit bierdie groep, maar daar is min
voordeel in die chirurgiese behandeling bo die konserwatiewe
behandeling.17 Nietemin meen ons dat angiografie tog in
bierdie gevalle uitgevoer moet word, aangesien dit reeds
gevind is dat wanneer bilaterale carotis-angiografie geen
letsel toon nie, die prognose relatief goed is.21 ,22
Hierdie gevalle laat dus 'n meer tydsame beslissing toe
oor wanneer .die ondersoek gedoen moet word.
OPSOMMING
1. In die lig van die gunstige sterftesyfer in Ask-Upmark
en Ingvar se reeks16 (28 %), is dit van belang dat die sterfte
in 88 pasiente in die Kaapstadse gebied ooreenkom hiermee3
(26'8%); en in gevalle wat konserwatief behandel.is en
wat hy 13 jaar lank opgevo)g het, vind BraakmanlS die
sterfte by sowel onmiddellike as langtermyn-opvolging in
bierdie opgewing (28 %) in 196 pasiente. Aangesien chirurgie 'n
sterfte dra wat wissel van 6 tot 33 %in verskillende reekse12-I4
(wat uit 'n baie heterogeen geselekteerde groep pasiente-
materiaal bestaan), is dit -waarskynlik belangrik dat kon-
serwatiewe behandeling oorweeg moet word in gebiede met
die laer sterfte.
2. Waarskynlik is die bedoeling met konserwatiewe
behandeling die vermindering van drukwisselinge van die
serebrospinale vog in gevalle met subarachnoiede bloeding,
en die keuring van die pasient en die besluit oor die optimale
tyd vir chirurgiese ingreep.
3. Deur die gevalle te klassifiseer volgens HolmesI7 se
voorstelle, rneen ons dat herhaalde lurnbale punksie en
bepaling van die graad van xantokromie hulp verleen by
hierdie keuring. Dit laat ook die uitsoek van gevalle toe
by wie langdurige rus in die bed ongewens is.
SUMMARY
1. In view of the favourable mortality rate reported by
Ask-Upmark and IngvarI6 (28 %), as compared with other
series, it is of interest that the mortality rate in 88 patients
in the Cape Town area of South Africa, corresponds to this
figure 3 (26' 8 %), and that in a 13-year follow-up study
Braakmanls found both the immediate and long-term
prognosis in 196 patients in this vicinity (28 %). As surgery
carries a mortality varying from 6 to 33 %12-14 in material
selected on a heterogeneous basis it would seem that in
areas with- such a relatively low mortality rate, conservative
treatment should be considered.
2. Probably some of the cbief aims of conservative
treatment are to minimize the fluctuation of pressure of tbe
cerebrospinal fluid in cases with spontaneous subarachnoid
haemorrhage, and to select the time and the patient for sur-
gical intervention.
3. In classifying the cases according to Holmes'
suggestions,n we feel that repeated lumbar puncture and
estimation of the degree ofxanthochromia present afford help
in this selection. It also allows for the selection of cases in
which prolonged bed rest would be undesirable as a guide
to early ambulation.
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mej. Y. Stuart vir die tikwerk verbonde aan die manuskrip. Ook
wiI ons drs. H. L. de Villiers Hammann en F. van iekerk van
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ARSENOBENZENE ENCEPHALOPATHY WITH RECOVERY
G. D. CAMPBELL, M.B., M.R.C.P. (EDIN.), Physician, Durban
Severe toxic reactions following the use of organic arsenicals
used to be fairly common. G1aser,1 in 1935, reported 1
death in every 2,700 patients treated with these preparations
in a series of 170,000: half these deaths were due to involve-
ment of the central nervous sy tern. A particularly severe
encephalopathy, 'fortunately rare? is among the neurological
reactions described.I-7 Organic arsenicals are still widely used
in non-specific conditions and, to emphasize the severity of
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reaction that sometimes OCCUTS after their use, the following
case of 'arsenobenzene encephalopathy' (Brain6) due to
intravenous ovarsenobillon ( AB) is recorded.
CASE REPORT
A 16-year-old schoolgirl was admitted to hospital on 20 November
1957. She had been quite well until 9 days before admission,
when she had been given 'an injection for acne into the vein'.
About 10 minute after this she collapsed in the street, but re-
covered quickly, having been unconscious for less than half a
minute. During the next week she felt a little unwell, but did not
have any particular complaints. She was noted to have taken
'a lot of aspirins' during that time.
Two days before admission, and exactly 1 week after the first
injection, he was given another intravenous injection, this time
the injection being 'covered by cortisone'. She had no immediate
ill-effects from this, and felt quite well until 48 hours after, when
she woke in the morning feeling a little off colour, ate her break-
fast with reluctance, and against the wishes of her father insisted
on going to school. On her arrival there she looked so unwell
that her teacher put her into the 'sick room', where she lay until
she was sent home at 3 o'clock in the afternoon. On reaching
home she complained of a headache, and said she was dizzy.
She felt :lauseated and her speech became confused. Shortly
after this she suddenly lost consciousness and was seized by the
most violent generalized convulsions. Each fit lasted for about
10 minutes, and they succeeded one another after intervals of
about 20 minutes, until she was seen by her doctor, who gave
her an intramuscular injection of 5 gr. of sodium luminal. She
vomited with the first 3 fits, but not again after this. There was
no previous history of epilepsy or of drug idiosyncrasy. Soon
after admission it was found that the injections had in fact been
NAB, the first of O· 15 mg. and the second of O· 30 mg.
When first seen the patient was unconscious and appeared
to be gravely ill; she did not respond to painful stimuli otherwise
than by having more seizures, which became more frequent as
the examination proceeded. Her pupils were dilated in the ex-
treme and did not respond to light. The retinae were normal.
There was no evidence of neck retraction or other sign of menin-
geal irritation. The blood pressure was 125/65 mm. Hg, and
the heart and abdomen were normal. There was no evidence of
aspiration pneumonia. The skin was normal, no rash or purpura
being seen.
Urine: Sugar 0·5%. Acetone +. Albumin +. Red cells-a
few present.
Blood: Haemoglobin 13· 2 g. %. Red cells 4·5 million per
c.mm. Blood sedimentation rate (Wintrobe) 34 mm. in the 1st
hour. White cells 16,000 per c.mm. (polymorphs 92%, 1ym-
phocytes 3 %, mononuclears 5 %). Red cells showed anisocytosis
and polychromasia, and basophilic stippling was present. The
platelets appeared to be increased, and there was a shift to the
left in the myeloid series, with toxic changes.
Lumbar puncture: Pressure 140 mm. of water. Total cell-count
less than 1 per c.mm. Globulin markedly increased. Sugar 87
mg. %. Protein 100 mg. %. Chlorides 730 mg. %.
A tentative diagnosis of arsenical encephalopathy was made,
and treatment started on that supposition. In all the patient
was unconscious for 5t days, and in extremis for the first 2 days.
!he fits were well controlled at first by intramuscular paraldehyde,
ID doses of up to 4 rnl. 4-hourly; although this was given by deep
injection, it raised some large urticarial wheals on each occasion
it was given. BAL (dimercaptol) therapy was started forthwith
in.a dosage of one 2 ml. ampoule (lOO mg.) every 6 hours, and
thlS was .kept up for 2 days. Intramuscular prednisolone was
given, in an initial dosage of 20 mg., and 10 mg. l2-hourly after
this for the first 3;' days. Soluble penicillin (500,000 units 12-
hourly) was given for the whole period of unconsciousness and
for a day after. An artificial airway was inserted soon after ad-
mission, and oxygen administered through it during an episode
of cyanosis on the second day; this airway was kept in position
with frequent changes, until the cough reflex was recovered. A~
indwelling urethral catheter was inserted with the usual sterile
precautions, and the bladder emptied at regular intervals, until
she regained consciousness.
On the 2nd day, in spite of heavy paraldehyde dosage, the
fits became more frequent and severe; the pulse rate rose to over
130 per minute and the respiration rate to 60 per minute. Tllere
was only slight pyrexia, to 99· oaF, and no signs of aspiration
pneumonia were seen. It was thought that the rise in heart rate
and respiration rate might be due to extreme brain-stem stimula-
tion which was not being affected by the paraldehyde, and so
morphia was cautiously substituted, in an initial trial dose of
1/6th gr. The response was most gratifying; the pulse rate dropped
to 100 per minute and the respirations to 24 per minute, and
the fits were well controlled. The dose of 1/6th g. of morphine
was repeated 6-hourly for the next day and 8-hourly for the
4th day; it was discontinued on the 5th day.
On the 3rd day after admission the patient developed a wide-
spread .blotchy erythematous rash, confined mostly to the body
but whIch was also seen on the arms and legs; this disappeared
withi? 2 ~ays, no 'purpura being.seen. At this time she was showing
defirute SIgnS of Improvement lD that smaller doses of morphine
were needed to stop the fits. Intravenous therapy was cautiously
started that day and 500 rnl. of 5% dextrose in saline run in.
This was followed by 1,500 rnl. on the 4th day; and on the 5th
she woke up after 500 ml. had been given, and intravenous fluids
were ~scontinued soon after, because she was able to take sips
of flmd by mouth almost at once. She had no other complaints
other than of being tired and thirsty and of having a headache.
Her recovery was complicated by. a mild degree of nausea and
vomiting, and she was discharged from hospital 10 days after
admission without any evidence of neurological sequelae. Her
urine was normal and has remained so. Six months later, she
says that she has had lapses of memory, which have lasted up to
a few hours on.2 occasioD:s; ther~ has ~en no headac)1e or weak·
ness, and she IS progressmg satisfactorily at a shorthand-typing
school. Neurological examination is normal.
DISCUSSION
ThIS syndrome seems to be clear cut: between 12 hOUTS and
6 days after an intravenous injection of NAB, generally the
2nd or 3rd of a course,5,2 the patient begins to feel ill.
Headache and drowsiness come on, and there -may be
vomiting. Confusion and coma set in, and in three-quarters
of the cases generalized convulsions occur.4,5 .Variable and
diffuse signs are seen.4 A scarlatiniform rash turning into a
haemorrhagic purpura was noted by one observer.8 The
ultimate mortality has not been determined but .one-quarter
of the cases die within 24 hOUTS of the onset of the iIIness.4
All the 4 cases of Nelson et al. 3 died. Three of them were
pregnant. In their article Nelson et al.3 added that 'most
cases' die, though recovery had been reported in 'several
instances'. Recovery, when it occurs, is generally complete,4
though residual disability has been noted.5 'Good results'
are said to have been obtained by nursing. the patients in an
upright posture. 7 A r_aised cerebrospinal-fluid protein was
considered unusual by one observer,2 though 'we noted it in
our case.
The actual cause of the syndrome is unknown; it has been
seen after only one injection, but it occurs more commonly
after the second or third.2,3,5· It is not seen invariably
in syphilitic patients,4,5 and this would -tend to rule out a
Herxheimer reaction. Neither the dosage3 nor the nature
of the radical2 appears to play any part in the genesis of
the syndrome. It probably represents an antigen-antibody
reaction, the brunt of which is borne by the nervous system-
a 'neuro-allergy'; even myelitis has been reported. 5 A 'direct
toxic action on the capillaries' has been suggested by the
results of the post-mortem examinations. 3 The brain shows
oedema and perivascular haemorrhages. 9 There is endothelial
swelling of the vessels with ante-mortem thrombus formation
and occasional vascular rupture.2 Gross cerebral haemorrhage
has also been reported. 5 The basal nuclei seem to be particu-
larly affected.3
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.
AB is still used fairly w~dely in practice in non-specific
conditions, notably stubborn mouth ulceration, in acne
vulgaris, and to induce remissions in disseminated clerosis.
In view of this it is important to remember that its u e some-
times causes severe illness and even death, and it hould be
reserved for those few cases of syphilis in which it is pecifically
indicated. When it is used, one should remember that it is
rapidly oxidized by atmospheric oxygen to a toxic sub tance,IO
and it should be injected as soon as the ampoule is opened.
If a case of encephalopathy is encountered, early use
should be made of BAL, and it would appear that treatment
should include prednisone or an allied drug in full doses
and an efficient anti-convulsant drug. With these drugs,
and the withdrawal of as much cerebrospinal fluid as possible
with the first lumbar puncture (if papilloedema is absent),
mere fluid restriction would seem preferable to repeated
lumbar punctures and the nursing of the patient in the
upright position,? since this must be a difficult measure to
introduce with patients as restless as these. Attention has
recently been drawn to the fact that the Landry-Guillain-
Barn~ syndrome may be a 'neuro-allergy', and impressive
results are said to have been obtained by the use of large
doses of cortisone.H Arsenobenzene encephalopathy, being
almost certainly a neuro-allergy, should probably be treated
with the same dosage; the doses used in this case (predniso-
lone, 20-30 mg. daily intramuscularly), though adequate,
were probably smaller than those needed for a maximum
margin of safety.
SUMMARY
To emphasize the need for restricting the indiscriminate use
of Novarsenobillon (NAB), a case of 'arsenobenzene en-
cephalopathy' is described in a 16-year schoolgirl who had
been given 2 intravenou injections for acne vulgari.
The extreme severity of the illnes , the clinical feature, the
laboratory findings and the method of treatment are described.
The patient made a complete recovery. The condition i
believed to be an allergic response. Its high mortality rate
is discussed and a plea made that AB should be used only
in tho e cases of s¥philis in ~vhich it is indicated. Attention
is drawn to the fact that TAB is rapidly oxidized by atmo -
pheric oxygen to a toxic ubstance, and hould be injected
as soon as the ampoule is opened.
I should like to acknowledge the very great kindness of the
Matron of SI. Augustine's Hospital, Durban, in allowing access
to the case notes; I am particularly grateful to Drs. G. A. Drum-
mond and J. E. Duncan Taylor for allowing me to quote the
results of their laboratory investigations. I should aI 0 like to
thank Dr. . A. Rossiter for his guidance in the case, and Dr.
J. Cosnett for his help with the preparation of the manuscript.
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DEHYDRATION IN CHILDREN SUFFERI G FROM PROTEI
(KWASHIORKOR) *
MAL UTRITIO
E. KAHN, M.D., M.R.C.P.E., D.C.H., Baragwanath Hospital, Johannesburg
The hallmark of protein malnutrition is an abnormally high
water content of the body, and the title of this paper refers
not to absolute values of body water content, but to clinical
evidence of dehydratio·n.
In this part of Africa severe diarrhoea is a common
phenomenon in patients suffering from protein malnutrition
(kwashiorkor). In up to 50% of cases it is caused by infection
with shigella and salmonella organisms,I while in the re-
mainder the cause is obscure. There is some evidence that
the coexistence in the same patient of protein malnutrition
and diarrhoea favours the development of dehydration,
which is one of the most fatal complications of malnutrition.
There is considerable disagreement on the question
whether diarrhoea influences the serum-electrolyte level of
patients suffering from protein malnutrition. Hansen et aP
found hypopotassaemia ID most of their cases, all of whom
were reported to be suffering from diarrhoea. The sodium
and chloride levels of their patients showed a wide scatter,
with subnormal levels present in only a few cases. The
potassium levels rose during treatment, while the sodium
and chloride levels remained unchanged. Politzer and Way-
• Paper presented at Third Congress ofSoutb African Paediatric
Association, Pretoria, October 1958.
burnes reported low serum-potassium levels in protein
malnutrition, but these were encountered irrespective of the
presence or absence of diarrhoea. Serum-sodium levels
were below 125 mEq. per litre in about. a quarter of their
patients, also irrespective of the association with diarrhoea.
Serum-sodium levels did not rise after dietetic treatment.
On the other hand, Heller and Scbnieden,< whose patients
did not suffer from diarrhoea or suffered only mildly, en-
countered normal sodium and potassium levels in patients
with protein malnutrition. Thompson5 supported the
findings of Heller and Schnieden. She found normal potas-
sium levels whether the patients were suffering from diarrhoea
or not. She was able to show low serum-potassium levels only
in patients with clinical evidence of hypopotassaemia.
It is unlikely that these discrepant findings were caused by
laboratory errors, because the electrolyte deterrninations
were carried out with flame photometers, instruments known
for their accuracy. Probably the inconsistencies are
attributable to differences in the selection of patients for
investigation. The different authors all divided their patients
into those with and those without diarrhoea, but the criteria
for the diagno is of diarrhoea were not stated. It is known
that in severe protein malnutrition intestinal absorption is
